Nutex Health (NASDAQ:NUTX) Releases Earnings Results, Beats Expectations By $4.63 EPS

Nutex Health (NASDAQ:NUTX) issued its earnings results on Thursday. The company reported $9.58 EPS for the quarter, topping analysts’ consensus estimates of $4.95 by $4.63, Zacks reports. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%.

Nutex Health Stock Performance

Shares of NASDAQ NUTX traded down $5.33 during trading hours on Thursday, reaching $151.93. The stock had a trading volume of 180,920 shares, compared to its average volume of 170,820. The firm has a 50-day moving average of $156.14 and a 200-day moving average of $128.98. The firm has a market cap of $1.05 billion, a price-to-earnings ratio of 11.74 and a beta of 0.24. The company has a current ratio of 3.14, a quick ratio of 3.12 and a debt-to-equity ratio of 0.66. Nutex Health has a fifty-two week low of $77.21 and a fifty-two week high of $204.00.

Analyst Ratings Changes

A number of analysts have weighed in on NUTX shares. Wall Street Zen cut Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. B. Riley Financial assumed coverage on Nutex Health in a research note on Friday, June 26th. They set a “buy” rating and a $290.00 target price for the company. Lake Street Capital started coverage on Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target for the company. Finally, Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $243.33.

Institutional Investors Weigh In On Nutex Health

Several large investors have recently modified their holdings of the company. Pertento Partners LLP increased its holdings in shares of Nutex Health by 20.0% in the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after acquiring an additional 54,001 shares during the period. Topline Capital Management LLC boosted its stake in Nutex Health by 72.0% during the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after purchasing an additional 129,418 shares during the period. Vanguard Group Inc. grew its position in Nutex Health by 12.7% during the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock worth $22,209,000 after purchasing an additional 24,275 shares during the last quarter. Millennium Management LLC grew its position in Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after purchasing an additional 61,308 shares during the last quarter. Finally, State Street Corp increased its stake in Nutex Health by 11.6% in the fourth quarter. State Street Corp now owns 86,792 shares of the company’s stock valued at $14,288,000 after purchasing an additional 9,052 shares during the period. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.